Chiesi USA
Chiesi USA, a NC-based specialty pharmaceutical subsidiary of Chiesi Farmaceutici, focuses on hospital and rare disease products.
Founded
2014Chiesi USA, a NC-based specialty pharmaceutical subsidiary of Chiesi Farmaceutici, focuses on hospital and rare disease products.
Founded in Cary, North Carolina, Chiesi USA is a specialty pharmaceutical company dedicated to the commercialization of products for hospitals, rare diseases, and targeted office-based specialties. As a Public Benefit Corporation, Chiesi USA aims to positively impact the communities it serves while meeting the evolving needs of its customers through an entrepreneurial approach. The company is a subsidiary of Chiesi Farmaceutici and employs approximately 300 people.
Chiesi USA has garnered attention for its commitment to corporate citizenship and its focus on niche medical markets. The company benefits from the expertise and resources of its parent organization, Chiesi Farmaceutici. Notable achievements include the successful launch of several specialty pharmaceutical products that address critical needs in healthcare. Through its innovative solutions and community-focused initiatives, Chiesi USA has made a significant impact on both the medical field and the communities it serves.
Companies similar to Chiesi USA include Assertio Holdings, US Specialty Formulations, Cumberland Pharmaceuticals and Catalyst Pharmaceuticals.
Chiesi USA was founded in 2014.
Chiesi USA's headquarters is located in Cary, NC, US.
Chiesi USA's most recent funding round was for $3k (USD) in August 2020.
As of Aug 4, 2020, Chiesi USA has disclosed funding of $3k (USD). Undisclosed round amounts are excluded.
Chiesi USA has 435 employees as of Feb 4, 2024.
Catalyst Pharmaceuticals
catalystpharma.com
